Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput screening by using a blue-fluorescent antibody sensor

Masayuki Matsushita1, Kazuhiro Yoshida, Noboru Yamamoto

  • 1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA. masayuki@scripps.edu

Angewandte Chemie (International Ed. in English)
|December 18, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.

Scientific reports·2021
Same author

Priorities, actions and risks in the COVID-19 pandemic: a flash SoMe survey among surgical oncologists.

Pleura and peritoneum·2021
Same author

Gastroenteropancreatic neuroendocrine tumor of the accessory papilla of the duodenum: a case report.

Surgical case reports·2021
Same author

Association of day of the week with mortality after elective right hemicolectomy for colon cancer: Case analysis from the National Clinical Database.

Annals of gastroenterological surgery·2021
Same author

Total laparoscopic excision of retroperitoneal ganglioneuroma: A case report.

International journal of surgery case reports·2021
Same author

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.

Gut·2021